Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome

Lila Bouadma, Aurélie Wiedemann, Juliette Patrier, Mathieu Surénaud, Paul-Henri Wicky, Emile Foucat, Jean‐Luc Diehl, Boris P. Hejblum, Fabrice Sinnah, Étienne de Montmollin, Christine Lacabaratz, Rodolphe Thiébaut, J. Timsit, Yves LévyJournal of Clinical Immunology 2020 · DOI

Abstract

We report a longitudinal analysis of the immune response associated with a fatal case of COVID-19 in Europe. This patient exhibited a rapid evolution towards multiorgan failure. SARS-CoV-2 was detected in multiple nasopharyngeal, blood, and pleural samples, despite antiviral and immunomodulator treatment. Clinical evolution in the blood was marked by an increase (2-3-fold) in differentiated effector T cells expressing exhaustion (PD-1) and senescence (CD57) markers, an expansion of antibody-secreting cells, a 15-fold increase in γδ T cell and proliferating NK-cell populations, and the total disappearance of monocytes, suggesting lung trafficking. In the serum, waves of a pro-inflammatory cytokine storm, Th1 and Th2 activation, and markers of T cell exhaustion, apoptosis, cell cytotoxicity, and endothelial activation were observed until the fatal outcome. This case underscores the need for well-designed studies to investigate complementary approaches to control viral replication, the source of the hyperinflammatory status, and immunomodulation to target the pathophysiological response. The investigation was conducted as part of an overall French clinical cohort assessing patients with COVID-19 and registered in clinicaltrials.gov under the following number: NCT04262921.

Introduction

Early in the COVID-19 pandemic, clinicians observed that severe cases often involved a "cytokine storm" and Acute Respiratory Distress Syndrome (ARDS), but the precise cellular mechanisms remained elusive. Specifically, it was unclear why some patients failed to clear the virus despite standard care and how the innate and adaptive immune systems transitioned from severe illness to fatal multiorgan failure. This paper, published in the Journal of Clinical Immunology, addresses the gap in longitudinal data by tracking a single patient’s immune system from admission to death, revealing a "perfect storm" of persistent viral replication and profound immune dysfunction.

Clinical Course and Methodology

The researchers conducted a detailed longitudinal analysis of an 80-year-old male patient in a French ICU. The study utilized a multi-pronged approach to capture the disease's progression:

  • Longitudinal Sampling: Blood and serum were collected on days 14, 16, 20, 22, and 24 after symptom onset.
  • Virological Monitoring: RT-PCR was used to track viral load across multiple sites, including nasopharyngeal swabs, blood, and pleural fluid.
  • Immunophenotyping: Flow cytometry was used to phenotype T cells (CD4+, CD8+, $\gamma\delta$), B cells, NK cells, and monocytes, specifically looking for markers of activation (HLA-DR, CD38), exhaustion (PD-1), and senescence (CD57).
  • Comparative Analysis: The patient’s data were compared against 5 healthy donors (HD) and 5 patients with non-COVID septic shock (SS) to distinguish COVID-specific signatures from general critical illness.
Clinical timeline, treatments, and sampling schedule for the fatal COVID-19 case.

Key Immunological Findings

The analysis revealed that death was associated with persistent viral shedding, the total disappearance of monocytes from the blood, and a massive expansion of unconventional immune cells. Unlike mild cases where the virus is cleared quickly, this patient showed persistent SARS-CoV-2 in the blood and pleural fluid until death, despite treatment with Remdesivir. This suggests that the "cytokine storm" may be a direct, failed response to an inability to control viral replication.

The researchers observed a total disappearance of monocytes from the peripheral blood, hypothesized to be due to "trafficking" into the lungs, where they likely contributed to devastating local inflammation. Furthermore, the adaptive immune system appeared to be "burning out," with a dramatic shift toward effector T cells expressing exhaustion (PD-1) and senescence (CD57) markers.

Longitudinal analysis of T cell subsets and activation markers (CD38/HLA-DR) demonstrating the shift toward differentiated and activated states.

Quantitative Results

  • $\gamma\delta$ T Cells: Reached 92% of all CD3+ T cells at one point, a 15-fold increase compared to healthy donors.
  • B Cell Activation: Antibody-secreting cells (plasmablasts) peaked at 34.3%, significantly higher than the 0.32% seen in healthy controls, indicating a massive but ultimately ineffective humoral response.
  • Cytokine Storm: Serum levels of IL-6, IL-10, IP-10, and MCP-1 were significantly higher than both healthy donors and septic shock patients.
  • NK Cells: A high frequency of differentiated NK cells (CD56dim CD57+) were actively cycling (Ki67+), peaking at 60.3% on day 16 before declining as the patient’s condition worsened.

Discussion and Conclusion

This case study underscores the need for well-designed studies to investigate complementary approaches to control viral replication and target the pathophysiological response. The authors suggest that future treatments must combine potent antivirals with highly specific immunomodulators rather than broad immunosuppression, which might further hinder viral clearance. While limited by its single-patient scope, this high-resolution longitudinal analysis provides a vital roadmap for understanding the cellular mechanisms of COVID-19 mortality and highlights the importance of timing in therapeutic intervention.

Summary updated

Abstract

We report a longitudinal analysis of the immune response associated with a fatal case of COVID-19 in Europe. This patient exhibited a rapid evolution towards multiorgan failure. SARS-CoV-2 was detected in multiple nasopharyngeal, blood, and pleural samples, despite antiviral and immunomodulator treatment. Clinical evolution in the blood was marked by an increase (2-3-fold) in differentiated effector T cells expressing exhaustion (PD-1) and senescence (CD57) markers, an expansion of antibody-secreting cells, a 15-fold increase in γδ T cell and proliferating NK-cell populations, and the total disappearance of monocytes, suggesting lung trafficking. In the serum, waves of a pro-inflammatory cytokine storm, Th1 and Th2 activation, and markers of T cell exhaustion, apoptosis, cell cytotoxicity, and endothelial activation were observed until the fatal outcome. This case underscores the need for well-designed studies to investigate complementary approaches to control viral replication, the source of the hyperinflammatory status, and immunomodulation to target the pathophysiological response. The investigation was conducted as part of an overall French clinical cohort assessing patients with COVID-19 and registered in clinicaltrials.gov under the following number: NCT04262921.
BibTeX
@article{bouadma2020immune,
  author = {Lila Bouadma and Aurélie Wiedemann and Juliette Patrier and Mathieu Surénaud and Paul-Henri Wicky and Emile Foucat and Jean‐Luc Diehl and Boris P. Hejblum and Fabrice Sinnah and Étienne de Montmollin and Christine Lacabaratz and Rodolphe Thiébaut and J. Timsit and Yves Lévy},
  title = {{Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome}},
  journal = {Journal of Clinical Immunology},
  year = {2020},
  doi = {10.1007/s10875-020-00839-x},
}
Figure